SANKAR NAVANEETHAN

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    K24HL161414     (NAVANEETHAN, SANKAR DASS)Jul 15, 2022 - Jun 30, 2027
    NIH
    MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE
    Role: Principal Investigator

    I01HX002917     (NAVANEETHAN, SANKAR DASS)Oct 1, 2020 - Sep 30, 2025
    NIH
    Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease
    Role: Co-Principal Investigator

    R01DK101500     (NAVANEETHAN, SANKAR DASS)Sep 22, 2014 - Jul 31, 2021
    NIH
    Visceral Adiposity and Physical Fitness in CKD
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gregg LP, Richardson PA, Nambi V, Petersen LA, Matheny ME, Virani SS, Navaneethan SD, Gregg LP, Richardson PA, Nambi V, Petersen LA, Matheny ME, Virani SS, Navaneethan SD. Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD. J Am Soc Nephrol. 2024 Aug 26. PMID: 39186372.
      Citations:    Fields:    
    2. Tuttle M, Sarnak MJ, Navaneethan SD. Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2024 Sep 01; 33(5):494-502. PMID: 38899951; PMCID: PMC11290985.
      Citations:    Fields:    Translation:HumansAnimals
    3. Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2024 04 29; 4:CD006257. PMID: 38682786; PMCID: PMC11057222.
      Citations:    Fields:    Translation:Humans
    4. Lamprea-Montealegre JA, Shapiro A, Bontrager NAB, Rifkin DE, Jassal SK, Gregg LP, Navaneethan SD, Navarra K, Shlipak MG, Estrella MM, Wang V. Cystatin C Use for CKD Detection in the Veterans Health Administration System: A Qualitative Study of Barriers and Facilitators. Kidney Med. 2024 Jun; 6(6):100830. PMID: 38799784; PMCID: PMC11127258.
      Citations:    
    5. Minhas AMK, Mathew RO, Sperling LS, Nambi V, Virani SS, Navaneethan SD, Shapiro MD, Abramov D. Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States. J Am Coll Cardiol. 2024 May 07; 83(18):1824-1826. PMID: 38583160.
      Citations:    Fields:    Translation:Humans
    6. Walther CP, Civitello AB, Lamba HK, Mondal NK, Navaneethan SD. Kidney Function Trajectories and Right Heart Failure Following LVAD Implantation. J Am Heart Assoc. 2024 Mar 05; 13(5):e031305. PMID: 38420763; PMCID: PMC10944080.
      Citations: 1     Fields:    Translation:Humans
    7. Holliday MW, Frost L, Navaneethan SD. Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens. 2024 05 01; 33(3):331-336. PMID: 38411162; PMCID: PMC11126299.
      Citations:    Fields:    Translation:Humans
    8. Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, Commodore-Mensah Y, Currie ME, Elkind MSV, Evenson KR, Generoso G, Heard DG, Hiremath S, Johansen MC, Kalani R, Kazi DS, Ko D, Liu J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Perman SM, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Tsao CW, Urbut SM, Van Spall HGC, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Palaniappan LP, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke St. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024 02 20; 149(8):e347-e913. PMID: 38264914.
      Citations: 91     Fields:    Translation:Humans
    9. Arney J, Gregg LP, Wydermyer S, Herrera MA, Richardson PA, Matheny ME, Akeroyd JM, Gobbel GT, Hung A, Virani SS, Navaneethan SD. Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study. Cardiorenal Med. 2024; 14(1):34-44. PMID: 38151011.
      Citations:    Fields:    Translation:Humans
    10. Amir S, Kim H, Hu EA, Ricardo AC, Mills KT, He J, Fischer MJ, Pradhan N, Tan TC, Navaneethan SD, Dobre M, Anderson CAM, Appel LJ, Rebholz CM, CRIC Study Investigators. Adherence to Plant-Based Diets and Risk of CKD Progression and All-Cause Mortality: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2024 05; 83(5):624-635. PMID: 38103719; PMCID: PMC11034716.
      Citations:    Fields:    
    11. Navaneethan SD, Mitch WE. Does Serum Creatinine Reflect Muscle Mass in Patients with Kidney Failure? J Am Soc Nephrol. 2024 01 01; 35(1):1-2. PMID: 38015564; PMCID: PMC10786607.
      Citations:    Fields:    Translation:Humans
    12. Ella K, Navaneethan SD. Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):401-403. PMID: 37530083; PMCID: PMC10403266.
      Citations:    Fields:    Translation:Humans
    13. Gregg LP, Worsley ML, Ramsey DJ, Segar MW, Matheny ME, Virani SS, Navaneethan SD. Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD. Clin J Am Soc Nephrol. 2023 11 01; 18(11):1479-1482. PMID: 37490295; PMCID: PMC10637447.
      Citations:    Fields:    Translation:Humans
    14. Gregg LP, Navaneethan SD. Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders? Nephrol Dial Transplant. 2023 05 31; 38(6):1355-1365. PMID: 36264349; PMCID: PMC10229268.
      Citations: 2     Fields:    Translation:Humans
    15. Gregg LP, Richardson PA, Herrera MA, Akeroyd JM, Jafry SA, Gobbel GT, Wydermyer S, Arney J, Hung A, Matheny ME, Virani SS, Navaneethan SD. Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease. Am J Nephrol. 2023; 54(3-4):126-135. PMID: 37231800; PMCID: PMC10424561.
      Citations:    Fields:    Translation:Humans
    16. Hussain A, Ramsey D, Lee M, Mahtta D, Khan MS, Nambi V, Ballantyne CM, Petersen LA, Walker AD, Kayani WT, Butler J, Slipczuk L, Rogers JG, Bozkurt B, Navaneethan SD, Virani SS. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942. PMID: 37204363.
      Citations: 3     Fields:    Translation:Humans
    17. Walther CP, Navaneethan SD. Echocardiographic parameters and cardiovascular disease in Japanese- and US-based CKD cohorts. Kidney Int. 2023 05; 103(5):837-839. PMID: 37085257.
      Citations:    Fields:    Translation:Humans
    18. Srivastava A, Navaneethan SD, Chen J, He J, Ishigami J, Kansal M, Mehta R, Rahman M, Dobre M, Al-Kindi SG, Go AS, Bhat ZY, Jaar BG, Appel LJ, Matsushita K, CRIC Study Investigators. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2023 08; 82(2):225-236. PMID: 36935072; PMCID: PMC10440229.
      Citations:    Fields:    Translation:Humans
    19. Sun DQ, Targher G, Byrne CD, Wheeler DC, Wong VW, Fan JG, Tilg H, Yuan WJ, Wanner C, Gao X, Long MT, Kanbay M, Nguyen MH, Navaneethan SD, Yilmaz Y, Huang Y, Gani RA, Marzuillo P, Boursier J, Zhang H, Jung CY, Chai J, Valenti L, Papatheodoridis G, Musso G, Wong YJ, El-Kassas M, M?ndez-S?nchez N, Sookoian S, Pavlides M, Duseja A, Holleboom AG, Shi J, Chan WK, Fouad Y, Yang J, Treeprasertsuk S, Cortez-Pinto H, Hamaguchi M, Romero-Gomez M, Al Mahtab M, Ocama P, Nakajima A, Dai C, Eslam M, Wei L, George J, Zheng MH. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surg Nutr. 2023 Jun 01; 12(3):386-403. PMID: 37351121; PMCID: PMC10282675.
      Citations: 4     
    20. Lorenz EC, Zaniletti I, Schinstock CA, Amer H, Cheville AL, LeBrasseur NK, Winkelmayer WC, Navaneethan SD, Kennedy CC, Rule AD, Johnson BK, Petterson TM, Kremers WK, Baez-Suarez A, Attia ZI, Lopez-Jimenez F, Friedman PA. Physiological Age by Artificial Intelligence-Enhanced Electrocardiograms as a Novel Risk Factor of Mortality in Kidney Transplant Candidates. Transplantation. 2023 06 01; 107(6):1365-1372. PMID: 36780487; PMCID: PMC10205652.
      Citations:    Fields:    Translation:Humans
    21. Desai NR, Navaneethan SD, Nicholas SB, Pantalone KM, Wanner C, Hamacher S, Gay A, Wheeler DC. Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice. J Diabetes Complications. 2023 04; 37(4):108411. PMID: 36857997.
      Citations: 2     Fields:    Translation:Humans
    22. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke St. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 02 21; 147(8):e93-e621. PMID: 36695182.
      Citations: 143     Fields:    Translation:Humans
    23. Gregg LP, Ramsey DJ, Akeroyd JM, Jafry SA, Matheny ME, Virani SS, Navaneethan SD. Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD. Am J Kidney Dis. 2023 07; 82(1):53-62.e1. PMID: 36702340; PMCID: PMC10293070.
      Citations: 1     Fields:    Translation:Humans
    24. Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Craig JC, Tunnicliffe DJ, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med. 2023 03; 176(3):381-387. PMID: 36623286.
      Citations: 3     Fields:    Translation:Humans
    25. Walther CP, Benoit JS, Bansal N, Nambi V, Navaneethan SD, CRIC Study Investigators. Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2023 04; 81(4):446-456. PMID: 36403887; PMCID: PMC10038859.
      Citations:    Fields:    Translation:Humans
    26. Rossing P, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Zoungas S, Craig JC, Tunnicliffe DJ, Tonelli MA, Cheung M, Earley A, de Boer IH. Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022 11; 102(5):990-999. PMID: 36272755.
      Citations: 18     Fields:    Translation:Humans
    27. Lamprea-Montealegre JA, Joshi P, Shapiro AS, Madden E, Navarra K, Potok OA, Gregg LP, Podchiyska T, Robinson A, Goldstein MK, Peralta CA, Jassal SK, Navaneethan SD, Rifkin DE, Wang V, Shlipak MG, Estrella MM. Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol. BMC Nephrol. 2022 10 12; 23(1):331. PMID: 36224528; PMCID: PMC9554861.
      Citations:    Fields:    Translation:Humans
    28. Hassanein M, Arrigain S, Schold JD, Nakhoul GN, Navaneethan SD, Mehdi A, Sekar A, Tabbara J, Taliercio JJ, CRIC Investigators. Dysnatremias, Mortality, and Kidney Failure in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Kidney Med. 2022 Dec; 4(12):100554. PMID: 36483992; PMCID: PMC9722469.
      Citations:    
    29. Taliercio JJ, Nakhoul G, Mehdi A, Yang W, Sha D, Schold JD, Kasner S, Weir M, Hassanein M, Navaneethan SD, Krishnan G, Kanthety R, Go AS, Deo R, Lora CM, Jaar BG, Chen TK, Chen J, He J, Rahman M, CRIC study Investigators. Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in?the Chronic Renal Insufficiency Cohort (CRIC) Study. Kidney Med. 2022 Nov; 4(11):100547. PMID: 36339663; PMCID: PMC9630782.
      Citations:    
    30. Dhanke JA, Maurya RK, Navaneethan S, Mavaluru D, Nuhmani S, Mishra N, Venugopal E. Recurrent Neural Model to Analyze the Effect of Physical Training and Treatment in Relation to Sports Injuries. Comput Intell Neurosci. 2022; 2022:1359714. PMID: 36210988; PMCID: PMC9546649.
      Citations:    Fields:    Translation:Humans
    31. Walther CP, Benoit JS, Lamba HK, Civitello AB, Erickson KF, Mondal NK, Liao KK, Navaneethan SD. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807. PMID: 36182652; PMCID: PMC10091513.
      Citations: 3     Fields:    Translation:Humans
    32. Holliday MW, Navaneethan SD. Editorial: Advancements in the management of kidney disease and electrolyte derangements. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):395-398. PMID: 35894272.
      Citations:    Fields:    Translation:Humans
    33. Walther CP, Benoit JS, Gregg LP, Bansal N, Nambi V, Feldman HI, Shlipak MG, Navaneethan SD, CRIC Study Investigators. Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index. Int J Obes (Lond). 2022 10; 46(10):1910-1917. PMID: 35978101; PMCID: PMC9710200.
      Citations:    
    34. Gregg LP, Van Buren PN, Ramsey DJ, Maydon A, Banerjee S, Walther CP, Virani SS, Winkelmayer WC, Navaneethan SD, Hedayati SS. Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1-3: a pilot study. J Investig Med. 2022 Jul 19. PMID: 35853670; PMCID: PMC10461401.
      Citations:    Fields:    
    35. Pozo Garcia L, Thomas SS, Rajesh H, Navaneethan SD. Progress in the management of patients with diabetes and chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):456-463. PMID: 35894280; PMCID: PMC9377049.
      Citations:    Fields:    Translation:Humans
    36. Ali S, Navaneethan SD, Virani SS, Gregg LP. Revisiting diuretic choice in chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):406-413. PMID: 35894274; PMCID: PMC9455225.
      Citations:    Fields:    Translation:Humans
    37. Joshi P, Navaneethan SD, Estrella MM. Moving Beyond Tools and Building Bridges: Lessons Learned From a CKD Decision Support in Primary Care. Kidney Med. 2022 Jul; 4(7):100497. PMID: 35789757; PMCID: PMC9250038.
      Citations:    
    38. Maitra NS, Mahtta D, Navaneethan S, Vaughan EM, Kochar A, Gulati M, Levine GN, Petersen LA, Virani SS. A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? Curr Cardiol Rep. 2022 06; 24(6):689-698. PMID: 35352278.
      Citations:    Fields:    Translation:Humans
    39. Al Rifai M, Vaughan EM, Abushamat LA, Lee M, Ramsey DJ, Gupta K, Navaneethan SD, Virani SS. Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 06 01; 172:7-10. PMID: 35305783.
      Citations:    Fields:    Translation:Humans
    40. Walther CP, Winkelmayer WC, Navaneethan SD. Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate. JAMA Netw Open. 2022 02 01; 5(2):e220460. PMID: 35166786; PMCID: PMC8848201.
      Citations:    Fields:    Translation:Humans
    41. Mahtta D, Ramsey DJ, Lee MT, Chen L, Al Rifai M, Akeroyd JM, Vaughan EM, Matheny ME, Navaneethan SD, Lavie CJ, Birnbaum Y, Ballantyne CM, Petersen LA, Virani SS, Santo KRDE. Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380. PMID: 35015080; PMCID: PMC8914426.
      Citations:    Fields:    Translation:Humans
    42. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS, Lewis TT. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 02 22; 145(8):e153-e639. PMID: 35078371.
      Citations: 65     Fields:    Translation:Humans
    43. Walther CP, Civitello AB, Liao KK, Navaneethan SD. Nephrology Considerations in the Management of Durable and Temporary Mechanical Circulatory Support. Kidney360. 2022 03 31; 3(3):569-579. PMID: 35582171; PMCID: PMC9034823.
      Citations:    Translation:Humans
    44. Al Rifai M, Mahtta D, Ramsey DJ, Lee MT, Krittanawong C, Navaneethan SD, Gregg LP, Petersen LA, Virani SS. Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. Am Heart J. 2022 06; 248:160-162. PMID: 34968441.
      Citations:    Fields:    Translation:Humans
    45. Vangala C, Shah M, Dave NN, Attar LA, Navaneethan SD, Ramanathan V, Crowley S, Winkelmayer WC. The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units. Ren Fail. 2021 Dec; 43(1):1146-1154. PMID: 34261420; PMCID: PMC8280999.
      Citations:    Fields:    Translation:Humans
    46. Richardson PA, Akeroyd J, Matheny ME, Virani SS, Gregg LP, Navaneethan SD. Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. Clin J Am Soc Nephrol. 2022 02; 17(2):283-285. PMID: 34799356; PMCID: PMC8823927.
      Citations: 1     Fields:    Translation:Humans
    47. Le P, Navaneethan SD, Yu PC, Pallotta AM, Rastogi R, Patel P, Brateanu A, Imrey PB, Rothberg MB. Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia. Curr Med Res Opin. 2022 Mar; 38(3):443-450. PMID: 34714213.
      Citations:    Fields:    Translation:Humans
    48. Gregg LP, Navaneethan SD. Considerations in the Study of Body Mass Index Variability. J Am Soc Nephrol. 2021 10; 32(10):2395-2397. PMID: 34599033; PMCID: PMC8722804.
      Citations:    Fields:    Translation:Humans
    49. Walther CP, Winkelmayer WC, Richardson PA, Virani SS, Navaneethan SD. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021 09 27; 36(10):1893-1899. PMID: 33367872; PMCID: PMC8633426.
      Citations: 3     Fields:    Translation:Humans
    50. Parvathareddy VP, Ella KM, Shah M, Navaneethan SD. Treatment options for managing obesity in chronic kidney disease. Curr Opin Nephrol Hypertens. 2021 09 01; 30(5):516-523. PMID: 34039849; PMCID: PMC8373688.
      Citations:    Fields:    Translation:Humans
    51. Gregg LP, Navaneethan SD. Are All SGLT2 Inhibitors Created Equal? Clin J Am Soc Nephrol. 2021 09; 16(9):1309-1311. PMID: 34497107; PMCID: PMC8729580.
      Citations:    Fields:    Translation:Humans
    52. Grams ME, Surapaneni A, Appel LJ, Lash JP, Hsu J, Diamantidis CJ, Rosas SE, Fink JC, Scialla JJ, Sondheimer J, Hsu CY, Cheung AK, Jaar BG, Navaneethan S, Cohen DL, Schrauben S, Xie D, Rao P, Feldman HI, CRIC study investigators. Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort?Study. Nephrol Dial Transplant. 2021 08 27; 36(9):1685-1693. PMID: 33326030; PMCID: PMC8396398.
      Citations: 3     Fields:    Translation:Humans
    53. Triozzi JL, Richardson PA, Gregg LP, Navaneethan SD. Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease. Nephrol Dial Transplant. 2021 07 23; 36(8):1546-1548. PMID: 33599279; PMCID: PMC8502472.
      Citations: 1     Fields:    Translation:Humans
    54. Slaven A, Hsu J, Schelling JR, Navaneethan SD, Rincon-Choles H, McAdams-DeMarco MA, Schachere M, O'Malley N, Deluca J, Lustigova E, Wang X, Kusek J, Porter AC, Lash JP, Rahman M, Horwitz E, CRIC Study investigators. Social Support in Older Adults With CKD: A Report From the CRIC (Chronic Renal Insufficiency Cohort) Study. Kidney Med. 2021 Sep-Oct; 3(5):776-784.e1. PMID: 34693258; PMCID: PMC8515062.
      Citations:    
    55. Triozzi JL, Parker Gregg L, Virani SS, Navaneethan SD. Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Res Care. 2021 07; 9(1). PMID: 34312158; PMCID: PMC8314731.
      Citations: 1     Translation:Humans
    56. Navaneethan SD, Walther CP, Winkelmayer WC. Black Race Coefficient in GFR Estimation and Prevalence of CKD-Related Complications. Clin J Am Soc Nephrol. 2021 10; 16(10):1562-1564. PMID: 34127483; PMCID: PMC8498997.
      Citations:    Fields:    Translation:Humans
    57. Al Rifai M, Jia X, Pickett J, Hussain A, Navaneethan SD, Birtcher KK, Ballantyne C, Petersen LA, Virani SS. Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. Popul Health Manag. 2022 02; 25(1):39-45. PMID: 34129402.
      Citations: 1     Fields:    Translation:Humans
    58. Hall RK, Blumenthal JB, Doerfler RM, Chen J, Diamantidis CJ, Jaar BG, Kusek JW, Kallem K, Leonard MB, Navaneethan SD, Sha D, Sondheimer JH, Wagner LA, Yang W, Zhan M, Fink JC, CRIC Study Investigators. Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 12; 78(6):837-845.e1. PMID: 34029681; PMCID: PMC8608689.
      Citations: 3     Fields:    Translation:Humans
    59. Navaneethan SD, Walther CP, Gregg LP, Bansal S, Winkelmayer WC, Nambi V, Niu J. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1. PMID: 33905766; PMCID: PMC8542055.
      Citations: 1     Fields:    Translation:Humans
    60. Navaneethan SD, Walther CP, Winkelmayer WC. Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates. J Am Soc Nephrol. 2021 06 01; 32(6):1319-1321. PMID: 33833077; PMCID: PMC8259644.
      Citations: 5     Fields:    Translation:Humans
    61. Schneider E, Remer EM, Obuchowski NA, McKenzie CA, Ding X, Navaneethan SD. Long-term inter-platform reproducibility, bias, and linearity of commercial PDFF MRI methods for fat quantification: a multi-center, multi-vendor phantom study. Eur Radiol. 2021 Oct; 31(10):7566-7574. PMID: 33768291.
      Citations:    Fields:    Translation:Humans
    62. Gregg LP, Navaneethan SD. Early eGFR decline after SGLT2i initiation: knowns and unknowns. Kidney Int. 2021 03; 99(3):548-550. PMID: 33637202.
      Citations:    Fields:    Translation:Humans
    63. Beddhu S, Boucher RE, Sun J, Balu N, Chonchol M, Navaneethan S, Chertow GM, Townsend R, Haley W, Cheung AK, Conroy MB, Raj DS, Xu D, George T, Yunis R, Wei G, Canton G, Bates J, Chen J, Papademetriou V, Punzi H, Wiggers A, Wright JT, Greene T, Yuan C. Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes. BMC Nephrol. 2021 02 24; 22(1):69. PMID: 33627066; PMCID: PMC7905597.
      Citations: 1     Fields:    Translation:Humans
    64. Walther CP, Ix JH, Biggs ML, Kizer JR, Navaneethan SD, Mukamal KJ, Djouss? L. Nonesterified Fatty Acids and Kidney Function Decline in Older Adults: Findings From the Cardiovascular Health Study. Am J Kidney Dis. 2021 08; 78(2):259-267. PMID: 33548344; PMCID: PMC8316278.
      Citations:    Fields:    Translation:Humans
    65. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke St, Lewis TT. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 02 23; 143(8):e254-e743. PMID: 33501848.
      Citations: 770     Fields:    Translation:Humans
    66. Gregg LP, Hedayati SS, Yang H, Van Buren PN, Banerjee S, Navaneethan SD, Virani SS, Winkelmayer WC, Alvarez CA. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959. PMID: 33423525; PMCID: PMC7878423.
      Citations: 5     Fields:    Translation:Humans
    67. Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 01 01; 36(1):129-136. PMID: 31641775.
      Citations: 10     Fields:    Translation:Humans
    68. Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wilkens KG, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K, Wanner C. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Ann Intern Med. 2021 03; 174(3):385-394. PMID: 33166222.
      Citations: 14     Fields:    Translation:Humans
    69. Chung EY, Ruospo M, Natale P, Bolignano D, Navaneethan SD, Palmer SC, Strippoli GF. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2020 10 27; 10:CD007004. PMID: 33107592; PMCID: PMC8094274.
      Citations: 12     Fields:    Translation:Humans
    70. Ali S, Ajmal MS, Navaneethan SD. Editorial: Management of cardiovascular risk factors and other comorbidities in chronic kidney disease. Curr Opin Nephrol Hypertens. 2020 09; 29(5):453-456. PMID: 32701601; PMCID: PMC7951612.
      Citations:    Fields:    
    71. Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, Dember LM, He J, Kusek JW, Lash JP, Navaneethan SD, Ojo A, Rahman M, Roy J, Scialla JJ, Sondheimer JH, Steigerwalt SP, Wilson FP, Wolf M, Feldman HI, CRIC Study Investigators. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 01; 77(1):56-73.e1. PMID: 32866540; PMCID: PMC7752839.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    72. Navaneethan SD, Kirwan JP, Remer EM, Schneider E, Addeman B, Arrigain S, Horwitz E, Fink JC, Lash JP, McKenzie CA, Rahman M, Rao PS, Schold JD, Shafi T, Taliercio JJ, Townsend RR, Feldman HI, CRIC Study Investigators. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55. PMID: 32798563; PMCID: PMC7752817.
      Citations: 7     Fields:    Translation:Humans
    73. Hu EA, Coresh J, Anderson CAM, Appel LJ, Grams ME, Crews DC, Mills KT, He J, Scialla J, Rahman M, Navaneethan SD, Lash JP, Ricardo AC, Feldman HI, Weir MR, Shou H, Rebholz CM, CRIC Study Investigators. Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2021 02; 77(2):235-244. PMID: 32768632; PMCID: PMC7855760.
      Citations: 15     Fields:    Translation:Humans
    74. de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wilkens KG, Zoungas S, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Rossing P, Wanner C. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020 10; 98(4):839-848. PMID: 32653403.
      Citations: 37     Fields:    Translation:Humans
    75. Vangala C, Niu J, Montez-Rath ME, Yan J, Navaneethan SD, Naik AD, Winkelmayer WC. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. J Am Soc Nephrol. 2020 06; 31(6):1325-1334. PMID: 32371535; PMCID: PMC7269355.
      Citations: 2     Fields:    Translation:Humans
    76. Triozzi JL, Niu J, Walther CP, Winkelmayer WC, Navaneethan SD. [Hospitalization and Critical Illness in Chronic Kidney Disease]. Cardiorenal Med. 2020; 10(5):302-312. PMID: 32316008.
      Citations:    Fields:    Translation:Humans
    77. Ghazi L, Yaffe K, Tamura MK, Rahman M, Hsu CY, Anderson AH, Fischer MJ, Miller ER, Navaneethan SD, He J, Weir MR, Townsend RR, Cohen DL, Feldman HI, CRIC Study Investigators, Cohen JB, Drawz PE. Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD. Clin J Am Soc Nephrol. 2020 04 07; 15(4):455-464. PMID: 32217634; PMCID: PMC7133123.
      Citations: 2     Fields:    Translation:Humans
    78. Walther CP, Nambi V, Hanania NA, Navaneethan SD. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020 06; 75(6):935-945. PMID: 32199709; PMCID: PMC7247937.
      Citations: 6     Fields:    Translation:Humans
    79. Malin SK, Navaneethan SD, Fealy CE, Scelsi A, Huang H, Rocco M, Kirwan JP. Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease. Obes Sci Pract. 2020 Jun; 6(3):307-312. PMID: 32523720; PMCID: PMC7278900.
      Citations: 3     
    80. Walther CP, Richardson PA, Virani SS, Winkelmayer WC, Navaneethan SD. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319. PMID: 30053252.
      Citations: 6     Fields:    Translation:Humans
    81. Navaneethan SD, Yan J, Deswal A. Classification of Pulmonary Hypertension in CKD. Am J Kidney Dis. 2020 05; 75(5):690-692. PMID: 32008859.
      Citations:    Fields:    Translation:Humans
    82. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181. PMID: 31962311.
      Citations: 2     Fields:    Translation:Humans
    83. Airy M, Lenihan CR, Ding VY, Montez-Rath ME, Cheng J, Navaneethan SD, Wasse H, Winkelmayer WC. Association Between Type of Vascular Access Used in Hemodialysis Patients and Subsequent Kidney Transplant Outcomes. Kidney Med. 2019 Nov-Dec; 1(6):383-390. PMID: 32734218; PMCID: PMC7384366.
      Citations: 1     
    84. Vangala C, Niu J, Montez-Rath ME, Yan J, Navaneethan SD, Winkelmayer WC. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360. PMID: 31606233.
      Citations: 7     Fields:    Translation:Humans
    85. Shah A, Navaneethan SD. Editorial: Novel therapeutic options for management of electrolyte disorders. Curr Opin Nephrol Hypertens. 2019 09; 28(5):407-408. PMID: 31232711.
      Citations:    Fields:    
    86. Ali K, Jurkovitz CT, Kiryluk K, Park M, Kawamoto K, Shang N, Navaneethan SD, Narva AS, Drawz P, Norton JM. Development and Validation of a Pragmatic Electronic Phenotype for CKD. Clin J Am Soc Nephrol. 2019 09 06; 14(9):1306-1314. PMID: 31405830; PMCID: PMC6730512.
      Citations: 19     Fields:    Translation:Humans
    87. Navaneethan SD, Erickson KF. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127. PMID: 31345841; PMCID: PMC6682812.
      Citations:    Fields:    Translation:Humans
    88. Ali S, Dave N, Virani SS, Navaneethan SD. Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease. Curr Atheroscler Rep. 2019 06 22; 21(9):32. PMID: 31230129.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    89. Shao J, Buysse J, Bushinsky DA, Navaneethan SD. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2019 07 05; 14(7):1011-1020. PMID: 31196951; PMCID: PMC6625635.
      Citations: 29     Fields:    Translation:Humans
    90. Walther CP, Winkelmayer WC, Niu J, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658. PMID: 31160142.
      Citations: 2     Fields:    Translation:Humans
    91. Hsu RK, Hsu CY, McCulloch CE, Yang J, Anderson AH, Chen J, Feldman HI, He J, Liu KD, Navaneethan SD, Porter AC, Rahman M, Tan TC, Wilson FP, Xie D, Zhang X, Go AS, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators . Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study. Clin Kidney J. 2020 Feb; 13(1):55-62. PMID: 32082553; PMCID: PMC7025351.
      Citations: 1     
    92. Anumudu S, Airy M, Erickson KF, Navaneethan SD, Chang TI, Winkelmayer WC, Niu J. Predialysis Nephrology Care and Incident Atrial Fibrillation in Older Patients With?ESKD Initiating Dialysis. Kidney Int Rep. 2019 May; 4(5):679-687. PMID: 31080923; PMCID: PMC6506758.
      Citations:    
    93. Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Griffin BP, Nally JV, Desai MY, Navaneethan SD. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease. J Am Heart Assoc. 2019 02 05; 8(3):e009980. PMID: 30686093; PMCID: PMC6405577.
      Citations: 14     Fields:    Translation:Humans
    94. Navaneethan SD. Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss. Circulation. 2019 01 15; 139(3):376-379. PMID: 30640548; PMCID: PMC6336107.
      Citations: 1     Fields:    Translation:HumansAnimals
    95. Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M, CKD Prognosis Consortium (CKD-PC), Evans M, Lee BJ. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019 01 10; 364:k5301. PMID: 30630856; PMCID: PMC6481269.
      Citations: 44     Fields:    Translation:Humans
    96. Ramsey D, Ahmed ST, Mishra SR, Petersen LA, Muntner P, Winkelmayer WC, Ramanathan V, Navaneethan SD, Akeroyd JM, Ballantyne C, Virani SS. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850. PMID: 30498000; PMCID: PMC6302320.
      Citations: 7     Fields:    Translation:Humans
    97. Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, Navaneethan SD, Ramanathan V. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481. PMID: 30472701; PMCID: PMC6347016.
      Citations: 31     Fields:    Translation:Humans
    98. Saeed F, Arrigain S, Schold JD, Nally JV, Navaneethan SD. What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104. PMID: 30463082.
      Citations: 9     Fields:    Translation:Humans
    99. Niu J, Shah MK, Perez JJ, Airy M, Navaneethan SD, Turakhia MP, Chang TI, Winkelmayer WC. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331. PMID: 30449517; PMCID: PMC6389434.
      Citations: 6     Fields:    Translation:Humans
    100. Walther CP, Shah M, Navaneethan SD. Estimated GFR Decline and Tubular Injury Biomarkers With Intensive Blood Pressure Control. Am J Kidney Dis. 2019 01; 73(1):4-7. PMID: 30424915.
      Citations: 4     Fields:    Translation:Humans
    101. Bansal N, Xie D, Sha D, Appel LJ, Deo R, Feldman HI, He J, Jamerson K, Kusek JW, Messe S, Navaneethan SD, Rahman M, Ricardo AC, Soliman EZ, Townsend R, Go AS. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2018 12; 29(12):2859-2869. PMID: 30377231; PMCID: PMC6287862.
      Citations: 15     Fields:    Translation:Humans
    102. Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV, Nakhoul GN. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron. 2019; 141(1):31-40. PMID: 30368506.
      Citations: 7     Fields:    Translation:Humans
    103. Niu J, Lenihan CR, Mitch WE, Navaneethan SD, Vangala C, Winkelmayer WC. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541. PMID: 30262672; PMCID: PMC6218825.
      Citations: 7     Fields:    Translation:Humans
    104. Ali S, Dave N, Navaneethan SD. Emerging therapeutic options for management of anaemia in with patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2018 09; 27(5):329-330. PMID: 29939850.
      Citations:    Fields:    
    105. Airy M, Chang TI, Ding VY, Goldstein BA, Bansal N, Niu J, Navaneethan SD, Turakhia MP, Winkelmayer WC. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597. PMID: 29145634; PMCID: PMC6113645.
      Citations: 7     Fields:    Translation:Humans
    106. Shurrab M, Ko DT, Zayed Y, Navaneethan SD, Yadak N, Yaseen A, Kaoutskaia A, Qamhia W, Hamdan Z, Haj-Yahia S, Lee DS, Newman D, Healey JS, Harvey P, Crystal E. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients. J Interv Card Electrophysiol. 2018 Oct; 53(1):123-129. PMID: 30058056.
      Citations: 2     Fields:    Translation:Humans
    107. Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV, Navaneethan SD. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45. PMID: 30048961; PMCID: PMC6107349.
      Citations: 4     Fields:    Translation:Humans
    108. Cheema FH, Morgan JA, Walther CP, Niu J, Winkelmayer WC, Nair AP, Fedson SE, Deswal A, Navaneethan SD. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14). PMID: 29980520; PMCID: PMC6064848.
      Citations: 5     Fields:    Translation:Humans
    109. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622. PMID: 29784611.
      Citations: 1     Fields:    Translation:Humans
    110. Bansal N, Roy J, Chen HY, Deo R, Dobre M, Fischer MJ, Foster E, Go AS, He J, Keane MG, Kusek JW, Mohler E, Navaneethan SD, Rahman M, Hsu CY, CRIC Study Investigators. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study. Am J Kidney Dis. 2018 09; 72(3):390-399. PMID: 29784617; PMCID: PMC6109597.
      Citations: 11     Fields:    Translation:Humans
    111. Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7. PMID: 29699917; PMCID: PMC6064652.
      Citations: 8     Fields:    Translation:Humans
    112. Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Levey AS, Woodward M, Hemmelgarn B, Coresh J, K?ttgen A, Eckardt KU. Predicting timing of clinical outcomes in patients?with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018 06; 93(6):1442-1451. PMID: 29605094; PMCID: PMC5967981.
      Citations: 44     Fields:    Translation:Humans
    113. Walther CP, Chandra A, Navaneethan SD. Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease. Curr Opin Nephrol Hypertens. 2018 01; 27(1):16-22. PMID: 29045334; PMCID: PMC5907917.
      Citations: 1     Fields:    Translation:Humans
    114. Navaneethan SD, Mandayam S. Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease. Kidney Int Rep. 2018 Mar; 3(2):244-246. PMID: 29725628; PMCID: PMC5932301.
      Citations:    
    115. Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, He J, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY, CRIC Study Investigators. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2018 05; 71(5):657-665. PMID: 29217305; PMCID: PMC5915916.
      Citations: 24     Fields:    Translation:Humans
    116. Qureshi S, Lorch R, Navaneethan SD. Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease. Curr Hypertens Rep. 2017 Oct 18; 19(11):92. PMID: 29046987.
      Citations: 3     Fields:    Translation:Humans
    117. Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322. PMID: 29032376.
      Citations: 10     Fields:    Translation:Humans
    118. Walther CP, Whaley-Connell A, Navaneethan SD. Emerging therapeutic options for managing diabetic kidney disease. Curr Opin Nephrol Hypertens. 2017 09; 26(5):335-337. PMID: 28548994.
      Citations:    Fields:    
    119. Rehman H, Akeroyd JM, Ramsey D, Ahmed ST, Merchant AT, Navaneethan SD, Petersen LA, Virani SS. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database. Clin Cardiol. 2017 Nov; 40(11):1055-1060. PMID: 28841246; PMCID: PMC6490345.
      Citations: 3     Fields:    Translation:Humans
    120. for CRIC Study Investigators, Snitker S, Doerfler RM, Soliman EZ, Deo R, St Peter WL, Kramlik S, Fischer MJ, Navaneethan S, Delafontaine P, Jaar BG, Ojo A, Makos GK, Slaven A, Weir MR, Zhan M, Fink JC. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. Clin J Am Soc Nephrol. 2017 09 07; 12(9):1409-1417. PMID: 28793999; PMCID: PMC5586585.
      Citations: 5     Fields:    Translation:Humans
    121. Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV, Navaneethan SD. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427. PMID: 28778854; PMCID: PMC5586570.
      Citations: 19     Fields:    Translation:Humans
    122. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281. PMID: 28750929; PMCID: PMC5651196.
      Citations: 12     Fields:    Translation:Humans
    123. Navaneethan SD, Virani SS. Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk. J Am Heart Assoc. 2017 07 14; 6(7). PMID: 28710179; PMCID: PMC5586308.
      Citations: 2     Fields:    Translation:Humans
    124. Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1204-1210. PMID: 27220754; PMCID: PMC5837502.
      Citations: 8     Fields:    Translation:Humans
    125. Vangala C, Lenihan CR, Montez-Rath ME, Nair SS, Navaneethan SD, Ramanathan V, Winkelmayer WC. Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145. PMID: 28460645; PMCID: PMC5412039.
      Citations: 1     Fields:    Translation:Humans
    126. Kalantar-Zadeh K, Crowley ST, Beddhu S, Chen JLT, Daugirdas JT, Goldfarb DS, Jin A, Kovesdy CP, Leehey DJ, Moradi H, Navaneethan SD, Norris KC, Obi Y, O'Hare A, Shafi T, Streja E, Unruh ML, Vachharajani TJ, Weisbord S, Rhee CM. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease. Semin Dial. 2017 05; 30(3):251-261. PMID: 28421638; PMCID: PMC5418081.
      Citations: 15     Fields:    Translation:Humans
    127. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR, STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 02 16; 376(7):641-651. PMID: 28199805; PMCID: PMC5451258.
      Citations: 620     Fields:    Translation:Humans
    128. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV. Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198. PMID: 28196649; PMCID: PMC5526715.
      Citations: 18     Fields:    Translation:Humans
    129. Chang AR, Grams ME, Navaneethan SD. Bariatric Surgery and Kidney-Related Outcomes. Kidney Int Rep. 2017 Mar; 2(2):261-270. PMID: 28439568; PMCID: PMC5399773.
      Citations: 48     
    130. Chirakarnjanakorn S, Navaneethan SD, Francis GS, Tang WH. Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol. 2017 Apr 01; 232:12-23. PMID: 28108129; PMCID: PMC5316356.
      Citations: 22     Fields:    Translation:Humans
    131. Walther CP, Navaneethan SD. Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease. J Am Soc Nephrol. 2017 03; 28(3):723-725. PMID: 28049650; PMCID: PMC5328175.
      Citations: 2     Fields:    Translation:Humans
    132. Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M, CRIC Study Investigators. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for?death in chronic kidney disease. Kidney Int. 2017 03; 91(3):711-719. PMID: 28017325; PMCID: PMC5313324.
      Citations: 43     Fields:    Translation:HumansCells
    133. Airy M, Winkelmayer WC, Navaneethan SD. Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 11; 68(5):667-670. PMID: 27772629.
      Citations: 1     Fields:    Translation:Humans
    134. Kirwan JP, Malin SK, Scelsi AR, Kullman EL, Navaneethan SD, Pagadala MR, Haus JM, Filion J, Godin JP, Kochhar S, Ross AB. A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2016 Nov; 146(11):2244-2251. PMID: 27798329; PMCID: PMC5086786.
      Citations: 38     Fields:    Translation:Humans
    135. Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol. 2016 Aug 01; 1(5):548-56. PMID: 27434583; PMCID: PMC4992989.
      Citations: 39     Fields:    Translation:Humans
    136. Agrawal V, Navaneethan SD. Bariatric surgery for obesity-associated decline in?kidney function: filling the?knowledge gap? Kidney Int. 2016 07; 90(1):28-30. PMID: 27312446.
      Citations: 3     Fields:    Translation:Humans
    137. Yan J, Navaneethan SD. Copeptin and Decline in Kidney Function. Am J Nephrol. 2016; 44(1):19-21. PMID: 27348731; PMCID: PMC5408578.
      Citations: 1     Fields:    Translation:Humans
    138. de Boer IH, Kovesdy CP, Navaneethan SD, Peralta CA, Tuot DS, Vazquez MA, Crews DC, American Society of Nephrology Chronic Kidney Disease Advisory Group. Pragmatic Clinical Trials in CKD: Opportunities and Challenges. J Am Soc Nephrol. 2016 Oct; 27(10):2948-2954. PMID: 27283497; PMCID: PMC5042675.
      Citations: 21     Fields:    Translation:Humans
    139. Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database Syst Rev. 2016 May 31; (5):CD004683. PMID: 27243372; PMCID: PMC8520736.
      Citations: 13     Fields:    Translation:Humans
    140. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21. PMID: 27130720; PMCID: PMC5002238.
      Citations: 17     Fields:    Translation:Humans
    141. Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016 07; 30(5):944-50. PMID: 27114387.
      Citations: 43     Fields:    Translation:Humans
    142. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46. PMID: 26891053; PMCID: PMC4794258.
      Citations: 11     Fields:    Translation:Humans
    143. Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82. PMID: 26880461; PMCID: PMC4757850.
      Citations: 19     Fields:    Translation:Humans
    144. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Sarnak MJ, Woodward M, Iseki K, CKD Prognosis Consortium, Titze S, Stengel B. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016 Jan 12; 315(2):164-74. PMID: 26757465; PMCID: PMC4752167.
      Citations: 165     Fields:    Translation:Humans
    145. Navaneethan SD, Fealy CE, Scelsi AC, Arrigain S, Malin SK, Kirwan JP. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. Am J Nephrol. 2015; 42(4):274-81. PMID: 26495987; PMCID: PMC4711270.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    146. Andalib A, Aminian A, Khorgami Z, Navaneethan SD, Schauer PR, Brethauer SA. Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc. 2016 06; 30(6):2583-91. PMID: 26416373.
      Citations: 13     Fields:    Translation:Humans
    147. Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, Dweik RA, Rahman M, Chronic Renal Insufficiency Cohort Investigators. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J Am Soc Nephrol. 2016 Mar; 27(3):877-86. PMID: 26386072; PMCID: PMC4769189.
      Citations: 25     Fields:    Translation:Humans
    148. Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS. GFR Estimation Using ?-Trace Protein and ?2-Microglobulin in?CKD. Am J Kidney Dis. 2016 Jan; 67(1):40-8. PMID: 26362696; PMCID: PMC4695294.
      Citations: 49     Fields:    Translation:HumansCTClinical Trials
    149. Sharma S, Navaneethan SD. Predicting Mortality after Severe Acute Kidney Injury: A Step Forward but Not Close to the Finish Line. Am J Nephrol. 2015; 42(1):54-6. PMID: 26303823.
      Citations:    Fields:    Translation:Humans
    150. Navaneethan SD, Whaley-Connell A. BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1501-3. PMID: 26276139; PMCID: PMC4559514.
      Citations:    Fields:    Translation:Humans
    151. Denker M, Boyle S, Anderson AH, Appel LJ, Chen J, Fink JC, Flack J, Go AS, Horwitz E, Hsu CY, Kusek JW, Lash JP, Navaneethan S, Ojo AO, Rahman M, Steigerwalt SP, Townsend RR, Feldman HI, Chronic Renal Insufficiency Cohort Study Investigators. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 06; 10(11):2073-83. PMID: 26265715; PMCID: PMC4633788.
      Citations: 38     Fields:    Translation:Humans
    152. Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV, Navaneethan SD. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63. PMID: 26228532; PMCID: PMC4686260.
      Citations: 44     Fields:    Translation:Humans
    153. Saeed F, Adil MM, Vidal GA, Piracha BH, Nahab F, Khan AS, Navaneethan SD. Outcomes of transient ischemic attack in maintenance dialysis patients and those with chronic kidney disease. Nephrol Dial Transplant. 2016 Jan; 31(1):128-32. PMID: 26160895.
      Citations:    Fields:    Translation:Humans
    154. Navaneethan SD, Dweik RA. Elevated pulmonary pressure: A novel risk marker in kidney disease? Kidney Int. 2015 Jul; 88(1):7-9. PMID: 26126087.
      Citations: 2     Fields:    Translation:Humans
    155. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27. PMID: 26111859; PMCID: PMC4491299.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    156. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8. PMID: 26077569; PMCID: PMC4498966.
      Citations: 21     Fields:    Translation:Humans
    157. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20. PMID: 26045089; PMCID: PMC4587705.
      Citations: 39     Fields:    Translation:Humans
    158. Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Database Syst Rev. 2015 May 04; (5):CD007910. PMID: 25938479; PMCID: PMC10788770.
      Citations: 2     Fields:    Translation:Humans
    159. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015 May 03; 16:69. PMID: 26024966; PMCID: PMC4459709.
      Citations: 14     Fields:    Translation:Humans
    160. Navaneethan SD, Boulware LE, Sedor JR. Patients as stakeholders in setting kidney disease research priorities. Am J Kidney Dis. 2015 May; 65(5):641-3. PMID: 25919496.
      Citations:    Fields:    Translation:Humans
    161. Liu F, Bennett S, Arrigain S, Schold J, Heyka R, McLennan G, Navaneethan SD. Patency and Complications of Translumbar Dialysis Catheters. Semin Dial. 2015 Jul-Aug; 28(4):E41-7. PMID: 25800550; PMCID: PMC4836066.
      Citations: 6     Fields:    Translation:Humans
    162. Navaneethan SD, Malin SK, Arrigain S, Kashyap SR, Kirwan JP, Schauer PR. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis. 2015 Feb; 65(2):345-7. PMID: 25458664; PMCID: PMC4469901.
      Citations: 14     Fields:    Translation:Humans
    163. Wilson FP, Xie D, Anderson AH, Leonard MB, Reese PP, Delafontaine P, Horwitz E, Kallem R, Navaneethan S, Ojo A, Porter AC, Sondheimer JH, Sweeney HL, Townsend RR, Feldman HI, CRIC Study Investigators. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol. 2014 Dec 05; 9(12):2095-103. PMID: 25381342; PMCID: PMC4255402.
      Citations: 27     Fields:    Translation:Humans
    164. Opelami O, Sakhuja A, Liu X, Tang WH, Schold JD, Navaneethan SD. Outcomes of infected cardiovascular implantable devices in dialysis patients. Am J Nephrol. 2014; 40(3):280-7. PMID: 25323128; PMCID: PMC4216629.
      Citations: 5     Fields:    Translation:Humans
    165. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct; 37(10):2864-83. PMID: 25249672; PMCID: PMC4170131.
      Citations: 292     Fields:    Translation:Humans
    166. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014 Oct; 64(4):510-33. PMID: 25257325.
      Citations: 191     Fields:    Translation:Humans
    167. Navaneethan SD, Kirwan JP, Arrigain S, Schold JD. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol. 2014 Jul 08; 15:108. PMID: 25005601; PMCID: PMC4099406.
      Citations: 20     Fields:    Translation:Humans
    168. Saab G, Lam M, Navaneethan SD, Slatopolsky E. Should monitoring of fibroblast growth factor-23 levels in dialysis patients be a part of routine clinical practice? Semin Dial. 2014 Nov-Dec; 27(6):565-8. PMID: 25040017.
      Citations:    Fields:    Translation:Humans
    169. Saab G, Navaneethan SD, Slatopolsky E. Targeting parathyroid hormone levels in dialysis patients. Semin Dial. 2014 Nov-Dec; 27(6):562-5. PMID: 25040125.
      Citations: 1     Fields:    Translation:Humans
    170. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25. PMID: 24887302.
      Citations: 4     Fields:    Translation:Humans
    171. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2014 May 31; (5):CD007784. PMID: 24880031.
      Citations: 57     Fields:    Translation:Humans
    172. Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014 Apr 29; (4):CD007004. PMID: 24782282.
      Citations: 62     Fields:    Translation:Humans
    173. Hawkins M, Newman AB, Madero M, Patel KV, Shlipak MG, Cooper J, Johansen KL, Navaneethan SD, Shorr RI, Simonsick EM, Fried LF. TV Watching, but Not Physical Activity, Is Associated With Change in Kidney Function in Older Adults. J Phys Act Health. 2015 Apr; 12(4):561-8. PMID: 24762526; PMCID: PMC4816441.
      Citations: 12     Fields:    Translation:Humans
    174. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74. PMID: 24726629; PMCID: PMC4143431.
      Citations: 23     Fields:    Translation:Humans
    175. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV. Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol. 2014; 39(4):288-96. PMID: 24714513; PMCID: PMC4056768.
      Citations: 19     Fields:    Translation:Humans
    176. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR, STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014 May 22; 370(21):2002-13. PMID: 24679060; PMCID: PMC5451259.
      Citations: 533     Fields:    Translation:Humans
    177. Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GF. Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2014 Mar 31; (3):CD009297. PMID: 24683046; PMCID: PMC10656599.
      Citations: 12     Fields:    Translation:Humans
    178. Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik RA, Navaneethan SD. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63. PMID: 24578332; PMCID: PMC4011456.
      Citations: 18     Fields:    Translation:Humans
    179. Wing MR, Yang W, Teal V, Navaneethan S, Tao K, Ojo A, Guzman NN, Reilly M, Wolman M, Rosas SE, Cuevas M, Fischer M, Lustigova E, Master SR, Xie D, Appleby D, Joffe M, Kusek J, Feldman HI, Raj DS, Chronic Renal Insufficiency Cohort (CRIC) Study. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring). 2014 May; 22(5):1359-66. PMID: 24415732; PMCID: PMC4327849.
      Citations: 3     Fields:    Translation:Humans
    180. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K, DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15. PMID: 24508475; PMCID: PMC4117406.
      Citations: 22     Fields:    Translation:Humans
    181. Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2014 Jan 28; (1):CD005019. PMID: 24470059; PMCID: PMC8860132.
      Citations: 19     Fields:    Translation:Humans
    182. Stephen R, Jolly SE, Nally JV, Navaneethan SD. Albuminuria: when urine predicts kidney and cardiovascular disease. Cleve Clin J Med. 2014 Jan; 81(1):41-50. PMID: 24391106.
      Citations: 8     Fields:    Translation:Humans
    183. Kelly KR, Navaneethan SD, Solomon TP, Haus JM, Cook M, Barkoukis H, Kirwan JP. Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adults. Med Sci Sports Exerc. 2014; 46(5):920-6. PMID: 24614337; PMCID: PMC3991752.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    184. Malin SK, Navaneethan SD, Mulya A, Huang H, Kirwan JP. Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults. J Nutr Health Aging. 2014; 18(6):608-15. PMID: 24950152; PMCID: PMC4697740.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    185. Sakhuja A, Schold JD, Kumar G, Katzan I, Navaneethan SD. Nontraumatic subarachnoid hemorrhage in maintenance dialysis hospitalizations: trends and outcomes. Stroke. 2014 Jan; 45(1):71-6. PMID: 24253541.
      Citations: 3     Fields:    Translation:Humans
    186. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2013 Sep 11; (9):CD004289. PMID: 24022428; PMCID: PMC10754478.
      Citations: 35     Fields:    Translation:Humans
    187. Bravo EL, Navaneethan SD. Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers? Clin J Am Soc Nephrol. 2013 Oct; 8(10):1637-9. PMID: 23929926; PMCID: PMC3789348.
      Citations: 3     Fields:    Translation:Humans
    188. Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Chiesa A, Rule AD, Srinivas T, Schold JD, Navaneethan SD, Poggio ED. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant. 2013 Sep; 13(9):2342-51. PMID: 23865821; PMCID: PMC3886854.
      Citations: 15     Fields:    Translation:Humans
    189. Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10. PMID: 23769134; PMCID: PMC3783514.
      Citations: 22     Fields:    Translation:Humans
    190. Sakhuja A, Schold JD, Kumar G, Dall A, Sood P, Navaneethan SD. Outcomes of patients receiving maintenance dialysis admitted over weekends. Am J Kidney Dis. 2013 Oct; 62(4):763-70. PMID: 23669002; PMCID: PMC3783620.
      Citations: 6     Fields:    Translation:Humans
    191. Garg N, Thomas G, Jackson G, Rickard J, Nally JV, Tang WH, Navaneethan SD. Cardiac resynchronization therapy in CKD: a systematic review. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1293-303. PMID: 23660183; PMCID: PMC3731896.
      Citations: 15     Fields:    Translation:Humans
    192. Navaneethan SD, Jolly SE, Sharp J, Jain A, Schold JD, Schreiber MJ, Nally JV. Electronic health records: a new tool to combat chronic kidney disease? Clin Nephrol. 2013 Mar; 79(3):175-83. PMID: 23320972; PMCID: PMC3689148.
      Citations: 15     Fields:    Translation:Humans
    193. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52. PMID: 23411425; PMCID: PMC3675852.
      Citations: 26     Fields:    Translation:Humans
    194. Strippoli GF, Navaneethan SD, Nigwekar SU. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. 2013 Jan 31; (1):CD006740. PMID: 23440810.
      Citations: 2     Fields:    Translation:Humans
    195. Babayev R, Whaley-Connell A, Kshirsagar A, Klemmer P, Navaneethan S, Chen SC, Li S, McCullough PA, Bakris G, Bomback A, KEEP Investigators. Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 Mar; 61(3):404-12. PMID: 23260275.
      Citations: 17     Fields:    Translation:Humans
    196. Boulware LE, Tangri N, Ephraim PL, Scialla JJ, Sozio SM, Crews DC, Shafi T, Miskulin DC, Liu J, St Peter W, Jaar BG, Wu AW, Powe NR, Navaneethan SD, Bandeen-Roche K, DEcIDE ESRD Patient Outcomes in Renal Disease Study Investigators. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167. PMID: 23217181; PMCID: PMC3554422.
      Citations: 16     Fields:    Translation:Humans
    197. Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA, Schauer PR. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013 Jan-Feb; 9(1):7-14. PMID: 23211651.
      Citations: 31     Fields:    Translation:Humans
    198. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sarnak MJ, Schold JD. Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol. 2012; 36(3):219-27. PMID: 22948230; PMCID: PMC3542766.
      Citations: 3     Fields:    Translation:Humans
    199. Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012 Aug 21; 157(4):263-75. PMID: 22910937; PMCID: PMC3955032.
      Citations: 113     Fields:    Translation:Humans
    200. Sullivan C, Leon JB, Sayre SS, Marbury M, Ivers M, Pencak JA, Bodziak KA, Hricik DE, Morrison EJ, Albert JM, Navaneethan SD, Reyes CM, Sehgal AR. Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol. 2012 Oct; 7(10):1639-45. PMID: 22798540; PMCID: PMC3463214.
      Citations: 62     Fields:    Translation:Humans
    201. Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012 Jun 13; 344:e3533. PMID: 22695899; PMCID: PMC3374481.
      Citations: 26     Fields:    Translation:Humans
    202. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, Chronic Renal Insufficiency Cohort. Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1155-62. PMID: 22554719; PMCID: PMC3386678.
      Citations: 120     Fields:    Translation:Humans
    203. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Sarnak MJ, Nally JV. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34. PMID: 22553369; PMCID: PMC3408940.
      Citations: 7     Fields:    Translation:Humans
    204. Strippoli GF, Collaborative Depression and Sexual Dysfunction (CDS) in Hemodialysis Working Group, Vecchio M, Palmer S, De Berardis G, Craig J, Lucisano G, Johnson D, Pellegrini F, Nicolucci A, Sciancalepore M, Saglimbene V, Gargano L, Bonifati C, Ruospo M, Navaneethan SD, Montinaro V, Stroumza P, Zsom M, Torok M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Graziano G, Gentile G, Ferrari JN, Santoro A, Zucchelli A, Triolo G, Maffei S, Wollheim C, De Cosmo S, Manfreda VM, Hegbrant J. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012 Jun; 7(6):974-81. PMID: 22490876; PMCID: PMC3362315.
      Citations: 22     Fields:    Translation:Humans
    205. Fissell RB, Srinivas T, Fatica R, Nally J, Navaneethan S, Poggio E, Goldfarb D, Schold J. Preemptive renal transplant candidate survival, access to care, and renal function at listing. Nephrol Dial Transplant. 2012 Aug; 27(8):3321-9. PMID: 22422867.
      Citations: 7     Fields:    Translation:Humans
    206. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sehgal AR, Schold JD. Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond). 2012 Dec; 36(12):1585-90. PMID: 22290538; PMCID: PMC3342418.
      Citations: 19     Fields:    Translation:Humans
    207. Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group, Vecchio M, Palmer S, De Berardis G, Craig J, Johnson D, Pellegrini F, Nicolucci A, Sciancalepore M, Saglimbene V, Gargano L, Bonifati C, Ruospo M, Navaneethan SD, Montinaro V, Stroumza P, Zsom M, Torok M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Graziano G, Lucisano G, Gentile G, Ferrari JN, Santoro A, Zucchelli A, Triolo G, Maffei S, Wollheim C, De Cosmo S, Manfreda VM, Strippoli GF, Hegbrant J. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012 Jun; 27(6):2479-88. PMID: 22207325.
      Citations: 11     Fields:    Translation:Humans
    208. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402. PMID: 21885787; PMCID: PMC3359558.
      Citations: 68     Fields:    Translation:Humans
    209. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2364-73. PMID: 21852664; PMCID: PMC3186450.
      Citations: 208     Fields:    Translation:Humans
    210. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Simon JF, Srinivas TR, Nally JV. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43. PMID: 21816525; PMCID: PMC3199572.
      Citations: 28     Fields:    Translation:Humans
    211. Raina R, Simon JF, Marion CR, Valeria A, Navaneethan SD, Heresi GA, Guzman JA, Wehbe E, Nally JV. Unusual cases of hydronephrosis with retroperitoneal fibrosis: mystery revealed. NDT Plus. 2011 Oct; 4(5):313-317. PMID: 21969844; PMCID: PMC3182259.
      Citations:    
    212. Demirjian SG, Raina R, Bhimraj A, Navaneethan SD, Gordon SM, Schreiber MJ, Guzman JA. 2009 influenza A infection and acute kidney injury: incidence, risk factors, and complications. Am J Nephrol. 2011; 34(1):1-8. PMID: 21625080.
      Citations: 16     Fields:    Translation:HumansCells
    213. Wehbe E, Salem C, Simon JF, Navaneethan SD, Pohl M. IgA-dominant Staphylococcus infection-associated glomerulonephritis: case reports and review of the literature. NDT Plus. 2011 Jun; 4(3):181-5. PMID: 25984152; PMCID: PMC4421616.
      Citations: 8     
    214. Maione A, Navaneethan SD, Graziano G, Mitchell R, Johnson D, Mann JF, Gao P, Craig JC, Tognoni G, Perkovic V, Nicolucci A, De Cosmo S, Sasso A, Lamacchia O, Cignarelli M, Manfreda VM, Gentile G, Strippoli GF. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials. Nephrol Dial Transplant. 2011 Sep; 26(9):2827-47. PMID: 21372254.
      Citations: 30     Fields:    Translation:Humans
    215. Navaneethan SD, Strippoli GF, Hegbrant J. Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2011 Mar; 20(2):146-52. PMID: 21245764.
      Citations: 3     Fields:    Translation:Humans
    216. Navaneethan SD, Palmer SC, Vecchio M, Craig JC, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database Syst Rev. 2011 Feb 16; (2):CD006023. PMID: 21328279.
      Citations: 26     Fields:    Translation:Humans
    217. Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505. PMID: 21085061.
      Citations: 3     Fields:    Translation:Humans
    218. Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, Ruospo M, Querques M, Jannini EA, Strippoli GF. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev. 2010 Dec 08; (12):CD007747. PMID: 21154382.
      Citations: 9     Fields:    Translation:Humans
    219. Smith A, Palmer S, Johnson DW, Navaneethan S, Valentini M, Strippoli GF. How to conduct a randomized trial. Nephrology (Carlton). 2010 Dec; 15(8):740-6. PMID: 21175959.
      Citations: 4     Fields:    Translation:Humans
    220. Navaneethan SD, Palmer SC, Smith A, Johnson DW, Strippoli GF. How to design a randomized controlled trial. Nephrology (Carlton). 2010 Dec; 15(8):732-9. PMID: 21091924.
      Citations: 2     Fields:    Translation:Humans
    221. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504. PMID: 21115622; PMCID: PMC3082406.
      Citations: 8     Fields:    Translation:Humans
    222. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ, Jain A, Nally JV. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol. 2011 Jan; 6(1):40-9. PMID: 21051745; PMCID: PMC3022247.
      Citations: 77     Fields:    Translation:Humans
    223. Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Wollheim C, Jannini EA, Strippoli GF, Hegbrant J. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis. 2010 Oct; 56(4):670-85. PMID: 20801572.
      Citations: 42     Fields:    Translation:Humans
    224. Kandula P, Dobre M, Schold JD, Schreiber MJ, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011 Jan; 6(1):50-62. PMID: 20876671; PMCID: PMC3022248.
      Citations: 102     Fields:    
    225. Schold JD, Sehgal AR, Srinivas TR, Poggio ED, Navaneethan SD, Kaplan B. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant. 2010 Sep; 10(9):2008-16. PMID: 20645941; PMCID: PMC3881969.
      Citations: 16     Fields:    Translation:Humans
    226. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010 Jul 06; 153(1):23-33. PMID: 20439566.
      Citations: 104     Fields:    Translation:Humans
    227. Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli GF. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010 Jun; 5(6):985-95. PMID: 20498250; PMCID: PMC2879298.
      Citations: 16     Fields:    Translation:Humans
    228. Jeevanantham V, Ntim W, Navaneethan SD, Shah S, Johnson AC, Hall B, Shah A, Hundley WG, Daubert JP, Fitzgerald D. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am J Cardiol. 2010 May 01; 105(9):1317-26. PMID: 20403486.
      Citations: 34     Fields:    Translation:Humans
    229. Navaneethan SD, Kandula P, Jeevanantham V, Nally JV, Liebman SE. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010 Apr; 73(4):260-7. PMID: 20353733.
      Citations: 21     Fields:    Translation:Humans
    230. Dobre M, Demirjian S, Sehgal AR, Navaneethan SD. Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol. 2011 Mar; 43(1):175-84. PMID: 20306131; PMCID: PMC3881971.
      Citations: 26     Fields:    Translation:Humans
    231. Palmer SC, Navaneethan SD, Strippoli GF. How to read a nephrology systematic review. Nephrology (Carlton). 2010 Mar; 15(2):158-64. PMID: 20470273.
      Citations: 1     Fields:    Translation:Humans
    232. Kandula P, Shah R, Singh N, Markwell SJ, Bhensdadia N, Navaneethan SD. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention. Nephrology (Carlton). 2010 Mar; 15(2):165-70. PMID: 20470274.
      Citations: 16     Fields:    Translation:Humans
    233. Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010 Mar; 20(3):308-15. PMID: 20217955; PMCID: PMC2891346.
      Citations: 27     Fields:    Translation:Humans
    234. Navaneethan SD, Schold JD, Srinivas TR. Metabolic syndrome and mild to moderate chronic kidney disease among minorities. Semin Nephrol. 2010 Jan; 30(1):51-8. PMID: 20116648.
      Citations: 2     Fields:    Translation:Humans
    235. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD006028. PMID: 19821351.
      Citations: 21     Fields:    Translation:Humans
    236. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1565-74. PMID: 19808241; PMCID: PMC2758256.
      Citations: 110     Fields:    Translation:Humans
    237. Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009 Oct; 54(4):619-37. PMID: 19692157.
      Citations: 42     Fields:    Translation:Humans
    238. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD004289. PMID: 19588351.
      Citations: 5     Fields:    Translation:Humans
    239. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD007004. PMID: 19588415.
      Citations: 17     Fields:    Translation:Humans
    240. Navaneethan SD, Palmer SC, Schreiber MJ, Strippoli GF. Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder. Nephrology (Carlton). 2009 Jun; 14(4):363-6. PMID: 19563376.
      Citations: 1     Fields:    Translation:Humans
    241. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD004289. PMID: 19370598.
      Citations: 12     Fields:    Translation:Humans
    242. Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD005019. PMID: 19370615.
      Citations: 12     Fields:    Translation:Humans
    243. Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD007784. PMID: 19370693.
      Citations: 54     Fields:    Translation:Humans
    244. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Mar; 4(3):542-51. PMID: 19261819; PMCID: PMC2653663.
      Citations: 78     Fields:    Translation:Humans
    245. Navaneethan SD, Yehnert H. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009 Nov-Dec; 5(6):662-5. PMID: 19359221.
      Citations: 36     Fields:    Translation:Humans
    246. Navaneethan SD, Taylor J, Goldman B, Bose A. Anti-neutrophil cytoplasmic antibody associated crescentic IgA nephropathy in hematopoietic stem cell transplantation. Clin Nephrol. 2009 Jan; 71(1):59-62. PMID: 19203551.
      Citations: 4     Fields:    Translation:Humans
    247. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Feb; 4(2):261-72. PMID: 19073785; PMCID: PMC2637582.
      Citations: 27     Fields:    Translation:Humans
    248. Navaneethan SD, Lohmeier TE, Bisognano JD. Baroreflex stimulation: A novel treatment option for resistant hypertension. J Am Soc Hypertens. 2009 Jan-Feb; 3(1):69-74. PMID: 20409946; PMCID: PMC3814230.
      Citations: 2     Fields:    
    249. Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant. 2009 Apr; 24(4):1260-6. PMID: 19033255; PMCID: PMC2721426.
      Citations: 28     Fields:    Translation:Humans
    250. Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Apr; 53(4):617-27. PMID: 19027212.
      Citations: 58     Fields:    Translation:Humans
    251. Collins M, Navaneethan SD, Chung M, Sloand J, Goldman B, Appel G, Rovin BH. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008 Dec; 52(6):1158-62. PMID: 18823685.
      Citations: 16     Fields:    Translation:Humans
    252. Ferrantino M, Navaneethan SD, Sloand JA. Pantoea agglomerans: an unusual inciting agent in peritonitis. Perit Dial Int. 2008 Jul-Aug; 28(4):428-30. PMID: 18556394.
      Citations: 5     Fields:    Translation:HumansCells
    253. Navaneethan SD, Nigwekar SU. Lack of permanent access in late referrals and its implications: not to be forgotten. Am J Med. 2008 Jun; 121(6):e17; author reply e19. PMID: 18501211.
      Citations:    Fields:    Translation:Humans
    254. Nigwekar SU, Rajda J, Navaneethan SD. Hospitalist care and length of stay in patients with hip fracture: a systematic review. Arch Intern Med. 2008 May 12; 168(9):1010-1. PMID: 18474766.
      Citations: 5     Fields:    Translation:Humans
    255. Navaneethan SD, Aloudat S, Singh S. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol. 2008 Feb 25; 9:3. PMID: 18298850; PMCID: PMC2291456.
      Citations: 46     Fields:    Translation:Humans
    256. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008 Mar 22; 336(7645):645-51. PMID: 18299289; PMCID: PMC2270960.
      Citations: 97     Fields:    Translation:Humans
    257. Navaneethan SD, Viswanathan G, Strippoli GF. Meta-analysis of mycophenolate mofetil in IgA nephropathy. Nephrology (Carlton). 2008 Feb; 13(1):90. PMID: 18199113.
      Citations: 2     Fields:    Translation:Humans
    258. Navaneethan SD, Mooney R, Sloand J. Pseudo-anion gap acidosis. NDT Plus. 2008 Apr; 1(2):94-96. PMID: 28657030; PMCID: PMC5477902.
      Citations:    
    259. Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost. 2008 Jan; 99(1):38-43. PMID: 18217132.
      Citations: 17     Fields:    Translation:Humans
    260. Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, Daubert J. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J. 2008; 15(3):230-6. PMID: 18651415.
      Citations: 7     Fields:    Translation:Humans
    261. Navaneethan SD, Viswanathan G, Strippoli GF. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs. 2008; 68(15):2095-104. PMID: 18840001.
      Citations: 7     Fields:    Translation:Humans
    262. Navaneethan SD, Jeevanantham V, Nigwekar SU. Prevalence and predictors of lack of permanent vascular access in early referrals. Am J Kidney Dis. 2007 Oct; 50(4):687. PMID: 17900473.
      Citations:    Fields:    Translation:Humans
    263. Navaneethan SD, Viswanathan G, Strippoli GF. Choice of extracorporeal dialysis modality: can it be evidence based? Minerva Urol Nefrol. 2007 Sep; 59(3):261-7. PMID: 17912223.
      Citations:    Fields:    Translation:Humans
    264. Viswanathan G, Navaneethan SD. An overlooked differential diagnosis of acute chest pain. South Med J. 2007 Aug; 100(8):850. PMID: 17713317.
      Citations:    Fields:    Translation:Humans
    265. Navaneethan SD, Nigwekar S, Sengodan M, Anand E, Kadam S, Jeevanantham V, Grieff M, Choudhry W. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007; 106(3):c113-8. PMID: 17522473.
      Citations: 17     Fields:    Translation:Humans
    266. Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC. Haemoglobin targets: we were wrong, time to move on. Lancet. 2007 Feb 03; 369(9559):346-50. PMID: 17276756.
      Citations: 17     Fields:    Translation:Humans
    267. Nigwekar SU, Navaneethan SD. Timely referral alone may not be enough for patients with chronic kidney disease. Mayo Clin Proc. 2007 Feb; 82(2):252-3. PMID: 17290737.
      Citations:    Fields:    Translation:Humans
    268. Bakare M, Shrivastava R, Jeevanantham V, Navaneethan SD. Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients. South Med J. 2007 Feb; 100(2):140-4. PMID: 17330682.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    269. Jeevanantham V, Shrivastava R, Nannapaneni S, Khan A, Sengodan M, Nautiyal A, Navaneethan S, Hsi D. Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea. Indian Heart J. 2007 Jan-Feb; 59(1):64-8. PMID: 19098338.
      Citations: 1     Fields:    Translation:Humans
    270. Navaneethan SD, Singh S. A systematic review of barriers in access to renal transplantation among African Americans in the United States. Clin Transplant. 2006 Nov-Dec; 20(6):769-75. PMID: 17100728.
      Citations: 49     Fields:    Translation:Humans
    271. Strippoli GF, Navaneethan SD, Craig JC. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD003967. PMID: 17054191.
      Citations: 17     Fields:    Translation:Humans
    272. Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD006257. PMID: 17054288; PMCID: PMC6956646.
      Citations: 59     Fields:    Translation:Humans
    273. Navaneethan SD, Bonifati C, Schena FP, Strippoli GF. Evidence for optimal hemoglobin targets in chronic kidney disease. J Nephrol. 2006 Sep-Oct; 19(5):640-7. PMID: 17136694.
      Citations: 5     Fields:    Translation:Humans
    274. Navaneethan SD, Kannan VS, Osowo A, Shrivastava R, Singh S. Concomitant intracranial aneurysm and carotid artery stenosis: A therapeutic dilemma. South Med J. 2006 Jul; 99(7):757-8. PMID: 16866060.
      Citations: 9     Fields:    Translation:Humans
    275. Navaneethan SD, Querques M, Bonifati C, Strippoli GF. Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection. Diabetes Educ. 2006 Jul-Aug; 32(4):596-602. PMID: 16873597.
      Citations:    Fields:    Translation:Humans
    276. Navaneethan SD, Sankarasubbaiyan S, Gross MD, Jeevanantham V, Monk RD. Tacrolimus-associated hypomagnesemia in renal transplant recipients. Transplant Proc. 2006 Jun; 38(5):1320-2. PMID: 16797291.
      Citations: 13     Fields:    Translation:Humans
    277. Navaneethan SD, Pansini F, Strippoli GF. Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Med. 2006 May; 3(5):e123. PMID: 16719546; PMCID: PMC1468443.
      Citations: 3     Fields:    Translation:HumansCells
    278. Navaneethan SD, Nautiyal A, Abdel-Gadir K, Shrivastava R, Parameswaran G, DiSalle MR, Haley J. Hospitalist physicians as educators in a community hospital: the trainee's view. South Med J. 2006 May; 99(5):550-1. PMID: 16711328.
      Citations:    Fields:    Translation:Humans
    279. Osowo A, Fetten J, Navaneethan S. Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms. South Med J. 2006 Feb; 99(2):188-9. PMID: 16509562.
      Citations: 3     Fields:    Translation:HumansCells
    280. Rivero M, Karlic A, Navaneethan SD, Singh S. Possible cocaine-induced acute renal failure without rhabdomyolysis. J Nephrol. 2006 Jan-Feb; 19(1):108-10. PMID: 16523435.
      Citations: 3     Fields:    Translation:Humans
    281. Bonifati C, Pansini F, Torres DD, Navaneethan SD, Craig JC, Strippoli GF. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice. Int J Artif Organs. 2006 Jan; 29(1):41-9. PMID: 16485238.
      Citations: 4     Fields:    Translation:Humans
    282. Navaneethan SD, Singh S, Choudhry W. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature. J Nephrol. 2005 Sep-Oct; 18(5):613-5. PMID: 16299690.
      Citations: 8     Fields:    Translation:Humans
    283. Navaneethan SD, Venkatesh S, Shrivastava R, Mehta J, Israel R. Recurrent pleural and pericardial effusions due to sarcoidosis. PLoS Med. 2005 Mar; 2(3):e63. PMID: 15783254; PMCID: PMC1069661.
      Citations: 6     Fields:    Translation:Humans
    284. Navaneethan S, Venkatesh S, Nannapaneni S, Shrivastava R. Educational intervention: a tool for decreasing medication errors. Int J Qual Health Care. 2005 Feb; 17(1):83. PMID: 15668315.
      Citations: 1     Fields:    Translation:Humans
    285. Navaneethan SD, Shrivastava R. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2004 Oct 18; (4):CD004289. PMID: 15495097.
      Citations: 3     Fields:    Translation:Humans
    NAVANEETHAN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (608)
    Explore
    _
    Co-Authors (42)
    Explore
    _
    Similar People (59)
    Explore
    _
    Same Department Expand Description
    Explore
    _